Skip to main content

Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer.

Publication ,  Journal Article
Greenup, RA; Blitzblau, RC; Houck, KL; Sosa, JA; Horton, J; Peppercorn, JM; Taghian, AG; Smith, BL; Hwang, ES
Published in: J Oncol Pract
April 2017

INTRODUCTION: Breast cancer treatment costs are rising, and identification of high-value oncology treatment strategies is increasingly needed. We sought to determine the potential cost savings associated with an evidence-based radiation treatment (RT) approach among women with early-stage breast cancer treated in the United States. PATIENTS AND METHODS: Using the National Cancer Database, we identified women with T1-T2 N0 invasive breast cancers treated with lumpectomy during 2011. Adjuvant RT regimens were categorized as conventionally fractionated whole-breast irradiation, hypofractionated whole-breast irradiation, and omission of RT. National RT patterns were determined, and RT costs were estimated using the Medicare Physician Fee Schedule. RESULTS: Within the 43,247 patient cohort, 64% (n = 27,697) received conventional RT, 13.3% (n = 5,724) received hypofractionated RT, 1.1% (n = 477) received accelerated partial-breast irradiation, and 21.6% (n = 9,349) received no RT. Among patients who were eligible for shorter RT or omission of RT, 57% underwent treatment with longer, more costly regimens. Estimated RT expenditures of the national cohort approximated $420.2 million during 2011, compared with $256.2 million had women been treated with the least expensive regimens for which they were safely eligible. This demonstrated a potential annual savings of $164.0 million, a 39% reduction in associated treatment costs. CONCLUSION: Among women with early-stage breast cancer after lumpectomy, use of an evidence-based approach illustrates an example of high-value care within oncology. Identification of high-value cancer treatment strategies is critically important to maintaining excellence in cancer care while reducing health care expenditures.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Oncol Pract

DOI

EISSN

1935-469X

Publication Date

April 2017

Volume

13

Issue

4

Start / End Page

e283 / e290

Location

United States

Related Subject Headings

  • Young Adult
  • Tumor Burden
  • Radiotherapy, Adjuvant
  • Radiotherapy Dosage
  • Postoperative Care
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Grading
  • Middle Aged
  • Mastectomy, Segmental
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Greenup, R. A., Blitzblau, R. C., Houck, K. L., Sosa, J. A., Horton, J., Peppercorn, J. M., … Hwang, E. S. (2017). Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer. J Oncol Pract, 13(4), e283–e290. https://doi.org/10.1200/JOP.2016.016683
Greenup, Rachel A., Rachel C. Blitzblau, Kevin L. Houck, Julie Ann Sosa, Janet Horton, Jeffrey M. Peppercorn, Alphonse G. Taghian, Barbara L. Smith, and E Shelley Hwang. “Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer.J Oncol Pract 13, no. 4 (April 2017): e283–90. https://doi.org/10.1200/JOP.2016.016683.
Greenup RA, Blitzblau RC, Houck KL, Sosa JA, Horton J, Peppercorn JM, et al. Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer. J Oncol Pract. 2017 Apr;13(4):e283–90.
Greenup, Rachel A., et al. “Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer.J Oncol Pract, vol. 13, no. 4, Apr. 2017, pp. e283–90. Pubmed, doi:10.1200/JOP.2016.016683.
Greenup RA, Blitzblau RC, Houck KL, Sosa JA, Horton J, Peppercorn JM, Taghian AG, Smith BL, Hwang ES. Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer. J Oncol Pract. 2017 Apr;13(4):e283–e290.

Published In

J Oncol Pract

DOI

EISSN

1935-469X

Publication Date

April 2017

Volume

13

Issue

4

Start / End Page

e283 / e290

Location

United States

Related Subject Headings

  • Young Adult
  • Tumor Burden
  • Radiotherapy, Adjuvant
  • Radiotherapy Dosage
  • Postoperative Care
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Grading
  • Middle Aged
  • Mastectomy, Segmental